No Data
No Data
Live Stock News: BABA is Back Baby, PLTR is Falling, Walmart Playing Second Fiddle
Goldman Sachs on Pace for Largest Percent Decrease Since August 2024 -- Data Talk
Dow Down 381 Points On Losses In Shares Of Walmart, Boeing
Big Banks: Seeking Alpha Analysts Vs. Wall Street
Alibaba Earnings Reports: AI drives cloud Business back to double-digit growth with over 0.09 million derivative models.
On February 20, Alibaba Group announced its third-quarter results for the fiscal year 2025 (natural year October-December 2024), showing an accelerated growth trend in Alibaba's core Business under the "AI-driven" Global Strategy. In this quarter, Alibaba Cloud's AI-related product revenue achieved triple-digit year-on-year growth for six consecutive quarters, helping Alibaba Cloud's revenue return to double-digit growth at 13%. The AI-driven marketing tool "Full Site Promotion" saw a steady increase in merchant penetration. Recently, Alibaba's brand new open-source flagship model Qwen2.5-Max gained significant attention, achieving globally leading results in multiple authoritative benchmark tests.
Ping An Health, Yidu Technology, and others have been selected for the Goldman Sachs China AI Medical Care Index Stocks basket.
Recently, Goldman Sachs released a report focusing on the investment prospects of AI in the Medical sector in China, believing that it contains huge investment opportunities. After a private enterprise forum, market confidence in Chinese AI companies has significantly improved. Meanwhile, with the release of DeepSeek, and the Outflow of funds from the capital-intensive "Seven Wonders" Sector towards the AI field, related companies' stock prices have continued to rise. From the development data perspective, the growth rate of AI in China is astonishing. From 2019 to 2023, the number of foundational models in China has rapidly increased, surpassing that of the European Union and United Kingdom. In the gradually maturing AI application.